TD Cowen Maintains Buy on HCA Healthcare, Lowers Price Target to $360
Portfolio Pulse from Benzinga Newsdesk
TD Cowen analyst Gary Taylor maintains a Buy rating on HCA Healthcare (NYSE:HCA) but lowers the price target from $371 to $360.
April 30, 2024 | 3:10 pm
News sentiment analysis
Sort by:
Descending
NEUTRAL IMPACT
TD Cowen maintains a Buy rating on HCA Healthcare but lowers the price target from $371 to $360.
The adjustment in price target by TD Cowen reflects a slight change in valuation expectations for HCA Healthcare, though the Buy rating indicates continued confidence in the company's performance. This could lead to mixed reactions in the short term, as investors weigh the reduced price target against the maintained positive outlook.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100